1. Home
  2. BHC vs NGVT Comparison

BHC vs NGVT Comparison

Compare BHC & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHC
  • NGVT
  • Stock Information
  • Founded
  • BHC N/A
  • NGVT 1964
  • Country
  • BHC Canada
  • NGVT United States
  • Employees
  • BHC N/A
  • NGVT N/A
  • Industry
  • BHC Biotechnology: Pharmaceutical Preparations
  • NGVT Major Chemicals
  • Sector
  • BHC Health Care
  • NGVT Industrials
  • Exchange
  • BHC Nasdaq
  • NGVT Nasdaq
  • Market Cap
  • BHC 2.2B
  • NGVT 2.1B
  • IPO Year
  • BHC N/A
  • NGVT N/A
  • Fundamental
  • Price
  • BHC $6.02
  • NGVT $55.41
  • Analyst Decision
  • BHC Hold
  • NGVT Buy
  • Analyst Count
  • BHC 2
  • NGVT 2
  • Target Price
  • BHC $9.00
  • NGVT $58.00
  • AVG Volume (30 Days)
  • BHC 1.3M
  • NGVT 221.8K
  • Earning Date
  • BHC 10-29-2025
  • NGVT 10-29-2025
  • Dividend Yield
  • BHC N/A
  • NGVT N/A
  • EPS Growth
  • BHC N/A
  • NGVT N/A
  • EPS
  • BHC 0.27
  • NGVT N/A
  • Revenue
  • BHC $9,858,000,000.00
  • NGVT $1,324,800,000.00
  • Revenue This Year
  • BHC $6.28
  • NGVT N/A
  • Revenue Next Year
  • BHC $3.76
  • NGVT $2.69
  • P/E Ratio
  • BHC $22.66
  • NGVT N/A
  • Revenue Growth
  • BHC 7.13
  • NGVT N/A
  • 52 Week Low
  • BHC $4.25
  • NGVT $28.49
  • 52 Week High
  • BHC $9.85
  • NGVT $60.77
  • Technical
  • Relative Strength Index (RSI)
  • BHC 32.55
  • NGVT 51.45
  • Support Level
  • BHC $5.90
  • NGVT $52.58
  • Resistance Level
  • BHC $6.19
  • NGVT $55.20
  • Average True Range (ATR)
  • BHC 0.19
  • NGVT 1.54
  • MACD
  • BHC -0.04
  • NGVT 0.00
  • Stochastic Oscillator
  • BHC 13.66
  • NGVT 58.47

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Share on Social Networks: